Think about the last time a celebrity’s before-and-after photos went viral, or a TikTok breaking down someone’s facelift showed up on your feed. Plastic surgery used to be one of the most private decisions a person could make. Now it’s party chatter.
RealSelf turns 20 this year, and we’ve not only had a front-row seat to that entire shift: we’ve helped drive it.
We launched in 2006 into a landscape where almost no one talked about having work done, let alone in public. If you were considering a procedure, your options were limited: ask a friend and hope they were being honest with you, scan a glossy brochure, or trust your gut in a consultation room with no way to compare outcomes or vet who you were sitting across from. Decisions were made quietly, and mostly alone. And no one shared the messy details of recovery or the rollercoaster of emotions that went along with it.
Now, celebrities post their surgeon’s name and implant size on Instagram. TikTok has turned recovery vlogs into a genre. Patients now arrive at consultations having already researched procedures, compared providers, and read hundreds of reviews, more informed and more opinionated than ever before.
The global beauty market is expected to grow 5% annually, reaching $590 billion by 2030, according to McKinsey’s latest State of Beauty report. That growth has brought a flood of information with it, and not all of it is trustworthy: AI-generated advice and unverified claims on social media are competing for the same attention as expertise from board-certified doctors.
Through all of it, RealSelf has stayed the constant: a vetted, trusted source for real outcomes and real provider expertise. That hasn’t changed in 20 years, and it isn’t changing now.
As we head into our next decade, we did a deep dive into RealSelf data to see what it reveals about how quickly and unpredictably aesthetics trends can change. Read on to find out the procedures and treatments that defined each year, along with insights from a provider who’s spent that same two decades in the treatment room, and our predictions for the next twenty.
Top Procedures and Treatments, By the Numbers
Breast augmentation has been the single most-searched procedure on RealSelf every year for a decade, without exception. In fact, no other surgical procedure has ever come close to challenging it for #1. It’s the one constant across ten years of shifting interest elsewhere.
Facial fat transfer shows a real, if quieter, reversal. After years of decline, from a top-15 surgical procedure in 2016-2018 down to a low of 19th-21st between 2020 and 2023, it turned a corner: #16 in 2024 and #15 in both 2025 and 2026, a modest but real shift back toward fat transfer over synthetic fillers.
Tummy tuck is the quiet consistency story of the decade. It’s held the #2 spot in four separate years (2016, 2017, 2019, 2022) and never fallen further than #4, even at its lowest. That low point lines up almost exactly with 2020 and 2021, the two years Brazilian Butt Lift and then Rhinoplasty each bumped it out of #2. By 2022 it was back at #2, and it’s settled into a steady #3 every year since, consistent if less attention-grabbing than the procedures cycling above and below it.
Eyelid surgery’s entrance into the surgical top 5 in 2023, and its climb to #4 by 2024, lines up with one of the most talked-about markers of a celebrity glow-up. Tired, hooded eyes opening up into a brighter, more alert look has become one of the most visibly identifiable transformations fans point to when a celebrity suddenly looks refreshed. More than a new nose or a fuller face, it’s the eyes that read as “different” first. That kind of speculation has become its own genre of content, with social media accounts dissecting exactly what changed and educating followers on what a blepharoplasty actually does, feeding curiosity back into platforms like RealSelf where people go to learn more and compare real patient results. It’s a slower-building trend than a single celebrity reveal or one viral moment, driven instead by a more informed audience actively researching what they’re seeing, and the search data reflects that: a steady climb in the ranks rather than a spike.
Botox has been a fixture at or near the top of non-surgical search interest for nearly a decade and held the #1 single-procedure spot in non-surgical searches every year since 2017. But when taken together, RealSelf’s dozens of skin tightening and lifting devices and techniques, including treatments like Ultherapy, Thermage, Morpheus8, Sofwave, and thread lifts, draw more views than Botox alone. 2026 is the first year that lead has been shrinking for several years, a sign the two may be converging.
In the combined surgical-plus-nonsurgical rankings, Botox first cracked the top 5 in 2017, dropped to #6 in 2019 and 7th in 2020 (both pandemic-adjacent years, when elective surgical procedures saw a widely reported “quarantine and recover” bump, sometimes called the Zoom Boom). It returned to the top 5 in 2021 and has climbed steadily since: #5 in 2021-2022, #4 in 2023, and #3 every year from 2024 on.
The bigger story isn’t Botox’s dominance. It’s that, taken together, RealSelf’s dozens of skin tightening and lifting devices and techniques have drawn more views than Botox alone for most of the last decade.
While it still hasn’t cracked the top 5, Sculptra’s climb is more evidence of the regenerative aesthetics trend in the data. It didn’t crack the non-surgical top 20 until 2022. The following year it jumped to #10, then #9 in 2024 and #6 in 2025, its best year yet. As a biostimulatory filler that triggers the body’s own collagen production, Sculptra’s rapid climb reflects a broader shift toward regenerative, longer-term treatments over immediate volume.
Callout: What about GLP-1s? RealSelf does track GLP-1-related content, Semaglutide, Tirzepatide, and Ozempic news and Q&A pages, but it lives outside the procedure taxonomy these rankings are built from, so it’s not a fair comparison to a procedure page.
Provider Perspective: What’s Changed, What Hasn’t
RealSelf data can tell you what people searched for. To add some color on why, we talked with a provider who’s actually been in the room with patients. Dr. Michael Salzhauer has been practicing plastic surgery for over 20 years, watching the same shifts play out in his own consultation room, patient by patient. We asked him what’s actually different about the person sitting across from him today compared to the one who walked in back in 2006.
On breast augmentation requests:
In 2006, the ask was simple: just make them bigger. Today, the same procedure comes with a much more specific brief: patients want their results “better, but subtle, natural. I don’t want anyone to know, but I do want to have curves.” The procedure hasn’t stood still either: techniques and implant technology have both advanced significantly over 20 years, but the bigger shift is in what the patient is actually asking for.
On body goals and the BBL:
From roughly 2010 to 2016, the ask on body contouring followed the same logic: go big. That’s shifted. Patients now more often want a smaller, more tempered result, a “skinny BBL” or are turning to alternative approaches like fat grafting rather than the larger, more dramatic augmentation that defined the procedure’s early boom.
On how patients show up to a consultation:
In 2006, a patient brought one magazine tear-out and pointed to it. That was the entire reference library. In 2026, patients arrive with what Dr. Salzhauer describes as a 47-slide “surgery inspo” deck, screenshots, saved posts, and side-by-side comparisons they’ve been building for months before ever booking an appointment.
On trend cycles, and what’s driving them now:
2006 had its “size zero craze.” Twenty years later, Dr. Salzhauer calls this moment the “Ozempidemic”: skinny is back in demand, but patients still want to hold onto some curve rather than return fully to the flatter ideal of two decades ago. It’s a preference shift with an obvious, specific driver this time, one that didn’t exist the last time this body type was popular.
His takeaway, twenty years in:
The techniques have genuinely changed, with better implants, better contouring approaches, more refined technique across the board. But what’s changed more, in his view, is the patient: what they want, how specific they are about it, and how much more accepted and normalized the entire category of plastic surgery has become. Patients today arrive more researched, more informed, and more self-directed than ever.
Dr. Michael Salzhauer, known worldwide as Dr. Miami, is an internationally recognized, board-certified plastic surgeon and the founder of the Dr. Miami practice in Bay Harbor Islands, Florida.
Our Predictions for the Next Twenty Years
If a decade of RealSelf’s own data has a single lesson, it’s that the biggest shifts rarely announce themselves. They show up quietly in the numbers years before anyone names them a trend. So instead of guessing at the next headline, we looked at what our data is already doing, what’s rising, what’s disappearing, and what’s rising back from the dead, and used it to make predictions about where beauty goes from here.
1. GLP-1s will show up in the data as a skin-tightening story just as much as a weight-loss one. GLP-1-related search interest is growing rapidly, despite being one of the newest treatment categories. The skin laxity left behind by rapid GLP-1-driven weight loss is already a widely discussed side effect, and RealSelf’s data shows the response to it. Interest in arm lifts, one of the go-to procedures for tightening loose skin after significant weight loss, has climbed in 2022, 2025, and 2026. Pair that with facelift climbing from #11 in 2016 to #6 in 2025 and eyelid surgery holding a permanent top-4 spot since 2024, and a pattern emerges across both face and body. Expect skin-tightening and lifting procedures, surgical and energy-device-based alike, to become one of the fastest-growing categories over the next 10 years, as that momentum continues to build.
2. Surgical technique itself is increasingly becoming a bigger differentiator than the procedure name. Two of the clearest examples sit on opposite ends of the body. In breast augmentation, the Preservé by Motiva technique places implants using specialized tools that separate tissue gently rather than cutting or cauterizing it, preserving the breast’s natural nerves, ligaments, and blood supply. The result is a meaningfully less invasive process than traditional implant placement. In facial rejuvenation, the deep plane facelift has become the industry’s new gold standard, repositioning deeper facial structures instead of just pulling and tightening skin, delivering more natural, longer-lasting results (often cited at 10-15 years) without the “windswept” look associated with older techniques. The numbers for deep plane facelift back up the story: its share of facelift reviews has grown from about a quarter in 2022 to about a third this year. Patients aren’t necessarily choosing different procedures: they’re increasingly choosing better-executed versions of the same ones.
3. Verified patient experience becomes the last trustworthy signal left, as everything else gets louder and less reliable. AI-generated advice, influencer endorsements, and unverified before-and-afters are already competing for the same attention as board-certified expertise. That noise is only going to get denser, harder to fact-check, and faster to spread over the next 20 years. Our prediction: real patient outcomes—verified, aggregated, and rated by the people who actually went through a procedure—become the only kind of information immune to misinformation, the same way verified reviews eventually became non-negotiable in travel and retail after enough fake ones flooded in. Communities built on firsthand insight won’t just be a nice-to-have anymore. They’ll be one of the few remaining checks on an information environment where it’s harder than ever to know what’s real.
Built on Trust. Ready for What’s Next.
Twenty years ago, someone considering plastic surgery had a single magazine photo and a leap of faith. Today, they have years of data, firsthand perspectives, and vetted providers.
Since 2006, RealSelf has been the one place to bring it all together, giving consumers the level of transparency they need to make these often high-stakes decisions. As AI-generated advice and unverified claims compete for the same attention as board-certified expertise, the need for a trusted source only grows: verified provider credentials, real patient reviews, treatment ratings, cost data based on what real people paid, actual before-and-afters, all in one place.
Patients don’t need more information. They need information they can trust. And we intend to be the most trusted resource for aesthetics for the next 20 years, too.
Credits and Methodology
This report wouldn’t exist without Alex Yu, Data Analytics Lead, who pulled and structured the underlying data, and Mari Malcolm, VP of Operations, who helped shape the analysis and copyedited the report.
Methodology note: For the purposes of this analysis, Breast Augmentation and Breast Implants have been combined into a single “Breast Augmentation” category, since both terms are commonly used interchangeably by patients searching for the same procedure. Similarly, “Botox” has become the generic term for neurotoxin injections, so this figure likely includes patients using the term as shorthand even when they mean neurotoxin treatments broadly. Other injectable neurotoxin brands, including Dysport, Xeomin, Jeuveau, and Daxxify, are tracked as separate categories and aren’t included in this number.
